doi: 10.7399/FH.2013.37.5.743.
[McHutchison's legacy and adherence in hepatitis C]
[Article in
Spanish]
- PMID: 24128108
- DOI: 10.7399/FH.2013.37.5.743
Item in Clipboard
[McHutchison's legacy and adherence in hepatitis C]
[Article in
Spanish]
Farm Hosp.
2013 Sep-Oct.
No abstract available
Similar articles
-
A modified ribavirin-free interferon therapy with boceprevir in post-liver transplant recurrent hepatitis C.J Clin Gastroenterol. 2014 May-Jun;48(5):464-5. doi: 10.1097/MCG.0000000000000037. J Clin Gastroenterol. 2014. PMID: 24275712 No abstract available.
-
PEG-IFN, RBV dosing during chronic HCV re-treatment.IAPAC Mon. 2007 Feb;13(2):55. IAPAC Mon. 2007. PMID: 17948601 No abstract available.
-
Impact of occult hepatitis B virus infection or hepatitis B virus DNA integration on efficacy of chronic hepatitis C treatment with peginterferon and ribavirin: where are we?J Clin Gastroenterol. 2014 Jan;48(1):3-5. doi: 10.1097/MCG.0b013e3182a6633d. J Clin Gastroenterol. 2014. PMID: 24045272 No abstract available.
-
[High dose repeat therapy in previously treated patients with chronic hepatitis C].Dtsch Med Wochenschr. 2006 Mar 17;131(11):543-4. doi: 10.1055/s-2006-933693. Dtsch Med Wochenschr. 2006. PMID: 16538557 Review. German. No abstract available.
-
Pushing the treatment envelope for chronic hepatitis C--is more necessarily better?Hepatology. 2005 Feb;41(2):234-6. doi: 10.1002/hep.20605. Hepatology. 2005. PMID: 15657958 Review. No abstract available.